Double Heron Pharmaceuticals (002038.SZ) has obtained the registration certificate for Dacomitinib tablets.

The Securities Times APP reported that Shuanglu Pharmaceutical (002038.SZ) announced that the company recently received the "Drug Registration Certificate" for Dasatinib Tablets (trade name: Xinfuda) issued by the National Medical Products Administration.